Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
KMT2C mutation
i
Other names:
MLL3, KMT2C, Lysine Methyltransferase 2C, Histone-Lysine N-Methyltransferase 2C, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 3, Lysine (K)-Specific Methyltransferase 2C, Histone-Lysine N-Methyltransferase, H3 Lysine-4 Specific, Myeloid/Lymphoid Or Mixed-Lineage Leukemia 3, Histone-Lysine N-Methyltransferase MLL3, Lysine N-Methyltransferase 2C, ALR-Like Protein, KLEFS2
Associations
(7)
News
Trials
C3 | Sensitive
C3 | Resistant
Show legend
Drug categories
Immunotherapy
CD Protein Inhibitors
Immune Checkpoint Inhibitors
Tyrosine Kinase Inhibitors
FGF
Cancel
Colorectal Cancer
Solid Tumor
Non Small Cell Lung Cancer
Hepatocellular Cancer
Renal Cell Carcinoma
Melanoma
Bladder Cancer
Immunotherapy
C3
KMT2C mutation
|
Colorectal Cancer
|
Immunotherapy
C3
KMT2C mutation
|
Solid Tumor
|
Immunotherapy
C3
KMT2C mutation
|
Non Small Cell Lung Cancer
|
Immunotherapy
C3
KMT2C mutation
|
Renal Cell Carcinoma
|
Immunotherapy
C3
KMT2C mutation
|
Melanoma
|
Immunotherapy
C3
KMT2C mutation
|
Bladder Cancer
|
Immunotherapy
PD1 inhibitor + lenvatinib
C3
KMT2C mutation
|
Hepatocellular Cancer
|
PD1 inhibitor + lenvatinib
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login